$68.52 - $85.65/hr
Clinical Biomarker Operations Specialist (m/f/d) CatalYm GmbH Full-time 60,000 - 75,000 € per year Your mission As Clinical Biomarker Operations Specialist, you will support operational planning ...
New
1 job near Columbus, OH
$68.52 - $85.65/hr
Clinical Biomarker Operations Specialist (m/f/d) CatalYm GmbH Full-time 60,000 - 75,000 € per year Your mission As Clinical Biomarker Operations Specialist, you will support operational planning ...
New
$68.52 - $85.65/hr
Clinical Biomarker Operations Specialist (m/f/d) CatalYm GmbH Full-time 60,000 - 75,000 € per year Your mission As Clinical Biomarker Operations Specialist, you will support operational planning ...
New
$68.52 - $85.65/hr
Other
Posted 3 days ago
New
CatalYm GmbH
Full-time
60,000 - 75,000 € per year
Your missionAs Clinical Biomarker Operations Specialist, you will support operational planning, coordination, and execution of clinical biomarker, translational sample, and bioanalytical activities across CatalYm’s clinical trials. You will help ensure that biomarker-related trial activities are implemented reliably, samples are collected and processed according to protocol requirements, vendors are qualified, contracted, and managed effectively, and biomarker and bioanalytical deliverables are completed on time and to a high standard.
You will work closely with Translational Research, Clinical Development, Clinical Operations, Clinical Pharmacology and Bioanalytics, Data Management, Biostatistics, Regulatory Affairs, Legal/Procurement, external laboratories, central laboratories, and CROs to support robust operational delivery of the clinical biomarker & bioanalytical program.
Your responsibilities include:
Who you are:
What we offer:
CatalYm is a biotech company based in Martinsried near Munich, developing innovative immunotherapies to transform cancer patients’ lives by effectively engaging their own immune systems to combat this malignant disease. We are now advancing to Phase 2b studies to confirm visugromab, our lead antibody, that has demonstrated durable anti-tumor efficacy with long-lasting objective responses in relapsed and refractory metastatic solid tumor patients in combination with anti-PD-1 treatment. Our mission is to rapidly bring our next-generation immuno-oncology products to patients in need. Are you ready to board the fast-accelerating visugromab train in Martinsried? Then join us!